Four 20 Pharma GmbH

Role Description Your mission: - Own the German commercial demand signal. - Build and maintain a rolling unconstrained demand plan for Germany at SKU level: - A 3-month rolling view. - An annual budget view. - A long-range outlook. - The unconstrained signal reflects what the market will absorb, independent of current supply availability. - Run a weekly forecasting cadence with the German commercial team, capturing input on: - Pipeline. - Customer behaviour. - Channel dynamics. - Translate qualitative commercial input into quantitative SKU-level numbers, with a documented set of assumptions that can be challenged and refined over time. - Hand the unconstrained demand signal to the Group Demand & S&OP Manager for supply-side constraint and reconciliation; partner with the S&OP function so the German signal feeds cleanly into the Group process. - Lock and sign off the demand signal at the start of each planning cycle so supply and finance plan against a stable number, not a moving target. - Run a monthly re-forecast process with the German commercial team and Finance; changes to the demand signal are governed and visible, not ad hoc. - Track forecast accuracy at SKU level, identify systemic biases, and continuously improve the quality of the demand signal. Market intelligence and competitor insight: - Work closely with Data team to maintain an ongoing review of competitor behaviour in the German market: - Product launches. - Range changes. - Channel shifts. - Commercial activity. - Support scenario planning: what does the demand signal look like under different pricing, regulatory or competitive scenarios? - Partner with the Group Data & Analytics team to industrialise the data feeds, dashboards and reporting that underpin this work. Long-range portfolio input: - Contribute the German market view to long-range portfolio planning, working with the Director of Commercial Operations and the Group team. - Surface insight on where the German market is heading — patient growth, channel mix, regulatory direction, indication trends — to inform the NPI and genetics roadmap. Qualifications - 5+ years in demand planning, commercial finance, sales operations, commercial analytics or a related commercial function, with a meaningful component of forecasting and/or market intelligence work. - Highly proficient in Excel, comfortable building SKU-level forecast models, and able to work with large datasets independently. - Demonstrated ability to translate qualitative commercial input into structured, defensible numbers — and to push back constructively when input is not credible. - Strong commercial instinct: understands how a commercial team thinks and operates, and earns credibility with sales colleagues quickly. - Fluent German and English, written and spoken. Requirements - Background in pharma, OTC, healthcare, FMCG or another regulated multi-market consumer or prescription environment. - Familiarity with S&OP processes and the interface between commercial demand planning and supply-side mechanics. - Experience with BI and analytics tools (Power BI, Tableau, SQL); willingness to work hands-on in the data. Benefits - A remote-first working model with a high degree of flexibility. - An attractive remuneration package. - A company pension scheme. - EGYM Wellpass, Corporate Benefits. - High-quality staff events and corporate functions. - Flexible working arrangements following a thorough induction. Company Description Four 20 Pharma GmbH is a pharmaceutical manufacturer, importer and wholesaler of medical cannabis based in Paderborn; since 2022, it has been part of Curaleaf Holdings, the world’s largest cannabis company, based in the USA. Our guiding principles are to improve patients’ quality of life by providing natural, pain-relieving medicines, and to ensure that patients have access to high-quality medical cannabis. With this mission, we have become one of the leading providers in Germany and, with our highly qualified and motivated team, we aim to realise further growth potential in Germany, Poland, Switzerland and other European countries.